# Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes

> **NCT00401622** · NA · COMPLETED · sponsor: **LifeScan** · enrollment: 320 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **BEHAVIORAL:** OneTouch® Ultra®2 System
- **BEHAVIORAL:** Standard care

## Key facts

- **NCT ID:** NCT00401622
- **Lead sponsor:** LifeScan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-01
- **Primary completion:** 2009-01-01
- **Final completion:** 2009-01-01
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2019-05-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00401622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00401622, "Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00401622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*